Professor Mohamed El-Kassas, M.D., is a distinguished hepatogastroenterologist and academic leader currently serving as Professor and Chief of Endemic Medicine and Hepato-Gastroenterology at the Faculty of Medicine, Helwan University, Cairo, Egypt. He holds a Postgraduate Diploma in Clinical Research from the University of Liverpool and is internationally recognized for his clinical expertise and scholarly contributions to the fields of viral hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD), and hepatocellular carcinoma (HCC). Driven by a deep commitment to patient-centered innovation and region-specific clinical advancement, Professor El-Kassas has dedicated his career to transforming hepatology practices in the MENA region. His work bridges evidence-based medicine with culturally relevant public health strategies, setting him apart as a key figure in international hepatology. His influence is especially noted in the establishment of MASLD as a regional priority through multidisciplinary research and policy initiatives. Professor El-Kassas has authored and co-authored over 250 peer-reviewed scientific articles, with many published as first or corresponding author in top-tier academic journals. His research has been cited extensively, earning him a Google Scholar h-index of 35. He has delivered over 100 invited lectures at international academic conferences and played leadership roles in numerous multicenter trials. His accolades include the Egypt State Encouraging Award in Medical Sciences (2016), the State Medal of Excellence (First Class, 2017), and the Best Arab Researcher Prize in Natural Sciences (2019). He is a board member of several professional associations, including the Global Council of the International Association for the Study of Liver (IASL), the Hepatology Committee of the World Gastroenterology Organization (WGO), and the Executive Board of the Africa Hepatopancreatobiliary Cancer Consortium (AHPBCC). In addition to his research achievements, Dr. El-Kassas has contributed extensively to academic publishing. He is currently Editor-in-Chief of the Gastrointestinal Medicine Journal and serves on the editorial boards of prestigious journals such as PLOS One, Frontiers in Medicine, and JCTH. Over the past decade, he has peer-reviewed more than 500 manuscripts and authored several editorials that have shaped the discourse around hepatology and gastroenterology in academic literature. His professional goals focus on advancing diagnostics and therapeutic strategies for liver diseases, particularly MASLD and viral hepatitis, through international collaboration and capacity building in under-resourced settings. He is the Founder and Chairman of the Steatotic Liver Diseases Study Foundation in the Middle East and North Africa (SLMENA), which fosters regional consensus, research, and advocacy efforts for liver diseases. Through his current role on the Egyptian Drug Authority’s Guidelines and Evidence Committee, he also contributes to national-level policy and clinical guideline development. Professor El-Kassas is widely recognized for his leadership, mentorship, and interpersonal skills. He has mentored over 50 graduate students and junior faculty, empowering the next generation of clinicians and researchers. His communication skills, problem-solving approach, and strategic vision have enabled him to successfully lead interdisciplinary teams, manage complex clinical trials, and coordinate high-impact international initiatives. He is known for his active listening and collaborative mindset, which he integrates into both academic and clinical environments. Outside of his professional commitments, Dr. El-Kassas enjoys reading classical literature, traveling, and photography. He frequently engages in community outreach activities, particularly during Ramadan, producing public health content in Arabic to improve liver disease awareness and promote healthy dietary habits. His multifaceted interests reflect a commitment not only to medicine but also to broader societal well-being.